Key principles for the improved conduct of health technology assessments for resource allocation decisions

被引:315
作者
Drummond, Michael F. [1 ]
Schwartz, J. Sanford [2 ,3 ,4 ]
Jonsson, Bengt [5 ]
Luce, Bryan R. [6 ]
Neumann, Peter J. [7 ,8 ]
Siebert, Uwe [9 ,10 ,11 ]
Sullivan, Sean D. [12 ]
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[2] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Hlth Care Management, Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA
[5] Stockholm Sch Econ, Dept Econ, SE-11383 Stockholm, Sweden
[6] United BioSource Corp, Dept Policy Sci, Bethesda, MD 20814 USA
[7] Tufts Univ, Medford, MA 02155 USA
[8] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA
[9] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Med Decis Making & Hlth Technol As, Eduard Wallnoefer Ctr 1, A-6060 Hall In Tirol, Austria
[10] Harvard Univ, MGH Inst Technol Assessment, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
[11] Harvard Univ, Dept Radiol, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA
[12] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA
关键词
cost-effectiveness analysis; health policy;
D O I
10.1017/S0266462308080343
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracing different types of assessments that inform real-world decisions about the value (i.e., benefits, risks, and costs) of new and existing technologies. Historically, most HTA agencies have focused on producing high quality assessment reports that can be used by a range of decision makers. However, increasingly organizations are undertaking or commissioning HTAs to inform a particular resource allocation decision, such as listing a drug on a national or local formulary, defining the range of coverage under insurance plans, or issuing mandatory guidance on the use of health technologies in a particular healthcare system. A set of fifteen principles that can be used in assessing existing or establishing new HTA activities is proposed, providing examples from existing HTA programs. The principal focus is on those HTA activities that are linked to, or include, a particular resource allocation decision. In these HTAs, the consideration of both costs and benefits, in an economic evaluation, is critical. It is also important to consider the link between the HTA and the decision that will follow. The principles are organized into four sections: (i) "Structure" of HTA programs; (ii) "Methods" of HTA; (iii) "Processes for Conduct" of HTA; and (iv) "Use of HTAs in Decision Making."
引用
收藏
页码:244 / 258
页数:15
相关论文
共 41 条
[1]
[Anonymous], 2003, EUR J HLTH EC, DOI DOI 10.1007/S10198-003-0205-2
[2]
*AUD COMM, 2005, MAN FIN IMPL NICE GU
[3]
Information created to evade reality (ICER) - Things we should not look to for answers [J].
Birch, Stephen ;
Gafni, Amiram .
PHARMACOECONOMICS, 2006, 24 (11) :1121-1131
[4]
A taxonomy of model structures for economic evaluation of health technologies [J].
Brennan, Alan ;
Chick, Stephen E. ;
Davies, Ruth .
HEALTH ECONOMICS, 2006, 15 (12) :1295-1310
[5]
Best practice in undertaking and reporting health technology assessments -: Working group 4 report [J].
Busse, R ;
Orvain, J ;
Velasco, M ;
Perleth, M ;
Drummond, M ;
Gürtner, F ;
Jorgensen, T ;
Jovell, A ;
Malone, J ;
Rüther, A ;
Wild, C .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2002, 18 (02) :361-422
[6]
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis [J].
Devlin, N ;
Parkin, D .
HEALTH ECONOMICS, 2004, 13 (05) :437-452
[8]
Drummond MF, 2005, METHODS EC EVALUATIO
[9]
Evidence-based medicine: A unified approach [J].
Eddy, DM .
HEALTH AFFAIRS, 2005, 24 (01) :9-17
[10]
Investigational treatments - How strict should we be? [J].
Eddy, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (03) :179-185